KRW 12460.0
(-0.4%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 48.54 Billion KRW | -2.1% |
2022 | 49.58 Billion KRW | 14.86% |
2021 | 43.16 Billion KRW | 36.32% |
2020 | 31.66 Billion KRW | 57.12% |
2019 | 20.15 Billion KRW | 11.37% |
2018 | 18.09 Billion KRW | 49.48% |
2017 | 12.1 Billion KRW | 45.23% |
2016 | 8.33 Billion KRW | -17.41% |
2015 | 10.09 Billion KRW | 47374.66% |
2014 | 21.26 Million KRW | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 14.72 Billion KRW | 6.08% |
2024 Q1 | 13.88 Billion KRW | -3.89% |
2023 FY | 48.54 Billion KRW | -2.1% |
2023 Q1 | 14.48 Billion KRW | 3.11% |
2023 Q2 | 14.09 Billion KRW | -2.74% |
2023 Q3 | 11.71 Billion KRW | -16.89% |
2023 Q4 | 14.44 Billion KRW | 23.35% |
2022 FY | 49.58 Billion KRW | 14.86% |
2022 Q4 | 14.05 Billion KRW | -44.67% |
2022 Q3 | 25.39 Billion KRW | 94.58% |
2022 Q2 | 13.05 Billion KRW | 19.39% |
2022 Q1 | 10.93 Billion KRW | 44.49% |
2021 Q2 | 11.54 Billion KRW | -16.82% |
2021 Q3 | 10.26 Billion KRW | -11.09% |
2021 FY | 43.16 Billion KRW | 36.32% |
2021 Q1 | 13.87 Billion KRW | 44.62% |
2021 Q4 | 7.56 Billion KRW | -26.29% |
2020 FY | 31.66 Billion KRW | 57.12% |
2020 Q4 | 9.59 Billion KRW | 33.41% |
2020 Q3 | 7.19 Billion KRW | 25.39% |
2020 Q2 | 5.73 Billion KRW | -4.01% |
2020 Q1 | 5.97 Billion KRW | -39.82% |
2019 Q2 | 4.36 Billion KRW | -0.49% |
2019 Q1 | 4.39 Billion KRW | 1697.5% |
2019 FY | 20.15 Billion KRW | 11.37% |
2019 Q4 | 9.92 Billion KRW | 115.73% |
2019 Q3 | 4.6 Billion KRW | 5.34% |
2018 Q2 | 4.79 Billion KRW | -5.73% |
2018 Q1 | 5.09 Billion KRW | 5.73% |
2018 Q3 | 3.17 Billion KRW | -33.89% |
2018 FY | 18.09 Billion KRW | 49.48% |
2018 Q4 | 244.26 Million KRW | -92.3% |
2017 FY | 12.1 Billion KRW | 45.23% |
2017 Q2 | 7.1 Billion KRW | 397.26% |
2017 Q1 | 1.42 Billion KRW | -28.99% |
2017 Q4 | 4.81 Billion KRW | 37.47% |
2017 Q3 | 3.5 Billion KRW | -50.74% |
2016 Q2 | 1.63 Billion KRW | 25.89% |
2016 FY | 8.33 Billion KRW | -17.41% |
2016 Q4 | 2.01 Billion KRW | 10.34% |
2016 Q3 | 1.82 Billion KRW | 11.68% |
2016 Q1 | 1.29 Billion KRW | -30.83% |
2015 Q4 | 1.87 Billion KRW | 59.93% |
2015 Q3 | 1.17 Billion KRW | -35.86% |
2015 Q2 | 1.82 Billion KRW | -93.2% |
2015 Q1 | 26.91 Billion KRW | 0.0% |
2015 FY | 10.09 Billion KRW | 47374.66% |
2014 FY | 21.26 Million KRW | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
NeoPharm CO., LTD. | 40.07 Billion KRW | -21.124% |